Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 June 1998 | Volume 128 Issue 11 | Pages 922-930
Purpose: To summarize the epidemiologic, diagnostic, and clinical features of the 32 laboratory-confirmed cases of human rabies diagnosed in the United States from 1980 to 1996.
Data Sources: Data were obtained from case reports of human rabies submitted to the Centers for Disease Control and Prevention by state or local health authorities.
Study Selection: All cases of human rabies reported in the United States from 1980 to 1996 in which infection with rabies virus was confirmed by laboratory studies.
Data Extraction: Patients were reviewed for demographic characteristics, exposure history, rabies prophylaxis, clinical presentation, treatment, clinical course, diagnostic laboratory tests, identification of rabies virus variants, and the number of medical personnel or family members who required postexposure prophylaxis after coming in contact with an exposed person.
Data Synthesis: 32 cases of human rabies were reported from 20 states. Patients ranged in age from 4 to 82 years and were predominantly male (63%). Most patients (25 of 32) had no definite history of an animal bite or other event associated with rabies virus transmission. Of the 32 cases, 17 (53%) were associated with rabies virus variants found in insectivorous bats, 12 (38%) with variants found in domestic dogs outside the United States, 2 (6%) with variants found in indigenous domestic dogs, and 1 (3%) with a variant found in indigenous skunks. Among the 7 patients with a definite exposure history, 6 cases were attributable to dog bites received in foreign countries and 1 was attributable to a bat bite received in the United States. In 12 of the 32 patients (38%), rabies was not clinically suspected and was diagnosed after death. In the remaining 20 cases (63%), the diagnosis of rabies was considered before death and samples were obtained specifically for laboratory confirmation a median of 7 days (range, 3 to 17 days) after the onset of clinical signs. Of the clinical differences between patients in whom rabies was diagnosed before death and those in whom it was diagnosed after death, the presence of hydrophobia or aerophobia was significantly associated with antemortem diagnosis (odds ratio, 11.0 [95% CI, 1.05 to 273.34]). The median number of medical personnel or familial contacts of the patients who received postexposure prophylaxis was 54 per patient (range, 4 to 179). None of the 32 patients with rabies received postexposure prophylaxis before the onset of clinical disease.
Conclusions: In the United States, human rabies is rare but probably underdiagnosed. Rabies should be included in the differential diagnosis of any case of acute, rapidly progressing encephalitis, even if the patient does not recall being bitten by an animal. In addition to situations involving an animal bite, a scratch from an animal, or contact of mucous membranes with infectious saliva, post-exposure prophylaxis should be considered if the history indicates that a bat was physically present, even if the person is unable to reliably report contact that could have resulted in a bite. Such a situation may arise when a bat bite causes an insignificant wound or the circumstances do not allow recognition of contact, such as when a bat is found in the room of a sleeping person or near a previously unattended child.
Author and Article Information
From National Center for Infectious Diseases, Atlanta, Georgia; and Centers for Disease Control and Prevention, Atlanta, Georgia. For current author addresses, see end of text.
REVIEW
Epidemiology of Human Rabies in the United States, 1980 to 1996
![]()
Acknowledgments: The authors thank the many state health department employees who provided epidemiologic and laboratory data on these cases; Pam Yager and past members of the Viral and Rickettsial Zoonoses Branch, who participated in the investigation and publication of some of the cases reviewed; and John O'Connor for careful editing.
Requests for Reprints: James E. Childs, ScD, Viral and Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop G-13, Atlanta, GA 30333.
Current Author Addresses: Dr. Noah: 902 Seminole Street, Frederick, MD 21701.
This article has been cited by other articles:
![]() |
Human Rabies--Indiana and California, 2006 JAMA, June 6, 2007; 297(21): 2340 - 2343. [Full Text] [PDF] |
||||
![]() |
A. L. Perez and A. E. Werchniak Antemortem Diagnosis of Rabies via Nuchal Skin Biopsy Arch Dermatol, May 1, 2007; 143(5): 663 - 663. [Full Text] [PDF] |
||||
![]() |
Human Rabies--Mississippi, 2005 JAMA, April 26, 2006; 295(16): 1892 - 1894. [Full Text] [PDF] |
||||
![]() |
P. L. Davis, E. C. Holmes, F. Larrous, W. H. M. Van der Poel, K. Tjornehoj, W. J. Alonso, and H. Bourhy Phylogeography, Population Dynamics, and Molecular Evolution of European Bat Lyssaviruses J. Virol., August 15, 2005; 79(16): 10487 - 10497. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Burton, D. K. Burns, M. J. Opatowsky, W. H. El-Feky, B. Fischbach, L. Melton, E. Sanchez, H. Randall, D. L. Watkins, J. Chang, et al. Rabies Encephalomyelitis: Clinical, Neuroradiological, and Pathological Findings in 4 Transplant Recipients Arch Neurol, June 1, 2005; 62(6): 873 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Srinivasan, E. C. Burton, M. J. Kuehnert, C. Rupprecht, W. L. Sutker, T. G. Ksiazek, C. D. Paddock, J. Guarner, W.-J. Shieh, C. Goldsmith, et al. Transmission of Rabies Virus from an Organ Donor to Four Transplant Recipients N. Engl. J. Med., March 17, 2005; 352(11): 1103 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
Recovery of a Patient From Clinical Rabies--Wisconsin, 2004 JAMA, February 9, 2005; 293(6): 669 - 670. [Full Text] [PDF] |
||||
![]() |
C. E. Rupprecht and R. V. Gibbons Prophylaxis against Rabies N. Engl. J. Med., December 16, 2004; 351(25): 2626 - 2635. [Full Text] [PDF] |
||||
![]() |
K. J. Guyatt, J. Twin, P. Davis, E. C. Holmes, G. A. Smith, I. L. Smith, J. S. Mackenzie, and P. L. Young A molecular epidemiological study of Australian bat lyssavirus J. Gen. Virol., January 1, 2003; 84(2): 485 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J Finnegan, S. M Brookes, N. Johnson, J. Smith, K. L Mansfield, V. L Keene, L. M McElhinney, and A. R Fooks Rabies in North America and Europe J R Soc Med, January 1, 2002; 95(1): 9 - 13. [Full Text] [PDF] |
||||
![]() |
P. H. Dennehy Active Immunization in the United States: Developments over the Past Decade Clin. Microbiol. Rev., October 1, 2001; 14(4): 872 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. KREBS, J. S. SMITH, C. E. RUPPRECHT, and J. E. CHILDS Mammalian Reservoirs and Epidemiology of Rabies Diagnosed in Human Beings in the United States, 1981-1998 Ann. N.Y. Acad. Sci., December 1, 2000; 916(1): 345 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Pleasure and N. J. Fischbein Correlation of Clinical and Neuroimaging Findings in a Case of Rabies Encephalitis Arch Neurol, December 1, 2000; 57(12): 1765 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Moran, D. A. Talan, W. Mower, M. Newdow, S. Ong, J. Y. Nakase, R. W. Pinner, J. E. Childs, and for the Emergency ID Net Study Group Appropriateness of Rabies Postexposure Prophylaxis Treatment for Animal Exposures JAMA, August 23, 2000; 284(8): 1001 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Glaser, P. Lewis, and S. Wong Pet-, Animal-, and Vector-borne Infections Pediatr. Rev., July 1, 2000; 21(7): 219 - 232. [Full Text] |
||||
![]() |
Human Rabies-- Virginia, 1998 JAMA, March 10, 1999; 281(10): 891 - 892. [Full Text] [PDF] |
||||
![]() |
Rabies Update Journal Watch Infectious Diseases, July 1, 1998; 1998(701): 8 - 8. [Full Text] |
||||
![]() |
Rabies in the U.S., 1980 to 1996 Journal Watch Emergency Medicine, July 1, 1998; 1998(701): 15 - 15. [Full Text] |
||||